Literature DB >> 23041378

An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan.

Kentaro Hayashi1, Nobutaka Horie, Kazuhiko Suyama, Izumi Nagata.   

Abstract

OBJECTIVES: Moyamoya disease (MMD) is a unique occlusive disease of the bilateral internal carotid arteries in which, compensation for occlusion results in an enrichment of collateral arteries at the base of the brain. However, the epidemiology of unilateral MMD (typical angiographic evidence of MMD unilaterally with equivocal contralateral findings), and quasi-MMD (MMD present with inherited or acquired disorders) is poorly known. Here, a nationwide epidemiological survey was conducted to estimate the total numbers of patients, the annual incidence rates and prevalences of MMD, unilateral MMD and quasi-MMD in Japan. PATIENTS AND METHODS: The neurosurgery, neurology and pediatrics departments that were listed in Japanese resident training programs were recruited to participate in this survey. Questionnaires were directly mailed to 2998 departments in February 2006.
RESULTS: A total of 1183 departments replied to the questionnaire (39.5% response rate). It was estimated that there were 6670.9 MMD patients, 840.5 unilateral MMD patients and 430.4 quasi-MMD patients in Japan. The annual incidence rates of MMD, unilateral MMD and quasi-MMD are 1.13, 0.23 and 0.11/100,000, respectively, and the prevalences are 5.22, 0.66 and 0.34/100,000, respectively. These patients were mainly treated by neurosurgeons. An estimated total of 929.1 surgical interventions are performed in Japan annually.
CONCLUSION: This nationwide study reports the current epidemiologic status of MMD, unilateral MMD and quasi-MMD in Japan.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23041378     DOI: 10.1016/j.clineuro.2012.09.020

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  10 in total

1.  Ischemic and hemorrhagic moyamoya disease in adults: CT findings.

Authors:  Anming Xie; Li Luo; Yaojun Ding; Gongjie Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Spontaneous intracranial hemorrhage as an initial manifestation of primary Sjögren's syndrome: a case report.

Authors:  Guo-Qiang Wang; Wei-Wei Zhang
Journal:  BMC Neurol       Date:  2013-07-29       Impact factor: 2.474

Review 3.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

4.  Coexistence of Quasi-moyamoya Disease and POEMS Syndrome in a Patient with Intracranial Hemorrhage: A Case Report and Literature Review.

Authors:  Izumi Yamaguchi; Junichiro Satomi; Nobuaki Yamamoto; Shotaro Yoshioka; Yoshiteru Tada; Kenji Yagi; Yasuhisa Kanematsu; Shinji Nagahiro
Journal:  NMC Case Rep J       Date:  2016-12-08

5.  The Contrast Enhancement of Intracranial Arterial Wall on High-resolution MRI and Its Clinical Relevance in Patients with Moyamoya Vasculopathy.

Authors:  Maoxue Wang; Yongbo Yang; Fei Zhou; Ming Li; Renyuan Liu; Maobin Guan; Rui Li; Le He; Yun Xu; Bing Zhang; Bin Zhu; Xihai Zhao
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

6.  Neuroendoscopic Findings of Ventricular Wall in Adult Hemorrhagic Moyamoya Disease: Report of Two Cases.

Authors:  Rei Yamaguchi; Hideaki Kohga; Masahiko Tosaka; Yuhei Yoshimoto; Shoichiro Ishihara
Journal:  NMC Case Rep J       Date:  2015-09-09

7.  Mood and Stress Evaluation of Adult Patients With Moyamoya Disease in Korea: Ecological Momentary Assessment Method Using a Mobile Phone App.

Authors:  Kyu Won Shim; Mona Choi; Yong Sook Yang; Gi Wook Ryu; Chang Gi Park; Insun Yeom
Journal:  JMIR Mhealth Uhealth       Date:  2020-05-25       Impact factor: 4.773

8.  Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.

Authors:  Lorelei D Shoemaker; Michael J Clark; Anil Patwardhan; Gemma Chandratillake; Sarah Garcia; Rong Chen; Alexander A Morgan; Nan Leng; Scott Kirk; Richard Chen; Douglas J Cook; Michael Snyder; Gary K Steinberg
Journal:  G3 (Bethesda)       Date:  2015-11-03       Impact factor: 3.542

9.  Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.

Authors:  Yixin Sun; Guoyu Zhou; Jingnan Feng; Lu Chen; Guozhen Liu; Jinxi Wang; Qingliang Wang; Junyou Yu; Xiwang Yang; Zheng Yang; Pei Gao; Shengfeng Wang; Siyan Zhan
Journal:  Stroke Vasc Neurol       Date:  2021-05-03

Review 10.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.